Clinical trials
Obesity clinical trials
Excess body weight that increases the risk of many other health conditions. We’re tracking 1,500 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06886126RecruitingPhase 2
Testing HDM1005 injection for weight loss in adults with obesity
This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.
NanjingAges 18–65 - NCT06890169Recruiting
One-stop telehealth program for weight and diabetes
This trial tests a telehealth program that helps people lose weight and manage type 2 diabetes and fatty liver disease at the same time. It's a one-stop remote clinic that combines medical advice, nutrition, and lifestyle support.
SingaporeAges 21–70 - NCT06891287RecruitingPhase 1
Testing an oral GLP-1/2 capsule in healthy volunteers
This study tests a new oral capsule that delivers a medicine called PG-102, which is a dual GLP-1/2 agonist (similar to drugs used for diabetes and weight loss). It is for healthy volunteers to see how the body handles the medicine. The study has two parts: one for people with a lower BMI and one for people with a higher BMI (over 30).
Melbourne, VictoriaAges 18–65 - NCT06893016RecruitingPhase 3
Study of RAY1225 for adults with obesity or overweight
This trial tests a new medicine called RAY1225 to help people lose weight. If you have obesity or are overweight with related health conditions, you may be able to join.
BeijingAges 18 years+ - NCT06896981RecruitingPhase 2/Phase 3
Semaglutide for women with PCOS and obesity
This study tests if a weekly injection called semaglutide can help women with PCOS and obesity lose weight and improve their health. It is for women who do not have other serious medical conditions.
Dhaka, Dhaka DivisionAges 10–45 - NCT06901739Recruiting
Synbiotic for mental health in obesity
This trial tests if a synbiotic (a mix of probiotics and prebiotics) can improve mental health in people with obesity. It may help if you have obesity and also struggle with anxiety or depression.
Valencia, ValenciaAges 18–65 - NCT06903923RecruitingPhase 2
Bone health in teens and young adults taking GLP-1 weight loss drugs
This trial looks at how GLP-1 receptor agonist medications (like liraglutide or semaglutide) affect bone health in adolescents and young adults with obesity. It aims to understand if these weight loss drugs have any impact on bone density and metabolism.
Charlottesville, VirginiaAges 12–21 - NCT06911203RecruitingPhase 2
Study of BGM0504 for people with obesity
This trial tests a new medicine called BGM0504 to help people with obesity lose weight. It may be an option if diet and exercise have not been enough and you qualify for a treatment study.
Beijing, Beijing MunicipalityAges 18–65 - NCT06918821Recruiting
Tiny Steps to Health: Helping Toddlers Play and Eat Well
This study tests a program that helps parents and toddlers ages 1.5 to 3 years learn healthy eating, active play, and physical activity in a group setting. It aims to reduce obesity by making healthy habits fun and easy for the whole family.
Houston, TexasAges 1.5 years–3 years - NCT06931730Recruiting
Exercise and cognitive training for overweight individuals
This trial tests a program that combines exercise, cognitive training, and social activities to help people with overweight or obesity manage their energy balance. It may improve overall health and weight control.
Rome, ItalyAges 6–11 - NCT06934642RecruitingEarly Phase 1
A study of tirzepatide for fatty liver disease in people with obesity
This trial tests if tirzepatide, a diabetes and weight loss medication, can help improve fatty liver disease in people who are overweight or have obesity. It may offer a new treatment option for managing liver health.
Albuquerque, New MexicoAges 18–75 - NCT06934681Recruiting
Exercise Program to Help Fight Obesity
This study tests whether a structured exercise program can help people with severe obesity lose weight and improve health. You will be asked to follow a supervised exercise routine to see if it helps you achieve your weight loss goals.
Valencia, ValenciaAges 18–65 - NCT06937060RecruitingPhase 3
Semaglutide for psoriasis and obesity
This trial tests if semaglutide, a medicine used for diabetes and weight loss, can help people with both psoriasis and obesity. You may qualify if you have moderate to severe psoriasis, a high body weight, and are of Chinese descent.
Hong KongAges 18–75 - NCT06948058Recruiting
E-cigarettes vs nicotine therapy for quitting smoking in obesity
This study compares e-cigarettes and nicotine replacement therapy (like patches or gum) to help people who are obese quit smoking. Participants use a study product for 8 weeks and track progress with a smartphone app.
Providence, Rhode IslandAges 21 years+ - NCT06966934Recruiting
Nasal airway and oxygen for stomach scope in obesity
This trial tests whether a breathing tube placed in the nose (nasopharyngeal airway) combined with high-flow oxygen can improve safety during painless gastroscopy in people with obesity. It may help you breathe better while sedated.
NanjingAges 18 years+ - NCT06971159Recruiting
Vibration therapy and osteopathic care for obesity
This study tests whether gentle whole-body vibration therapy and osteopathic manual treatment (hands-on adjustments) can help people with obesity. It aims to see if these treatments improve weight-related health and well-being.
Rio de Janeiro, Rio de JaneiroAges 18–65 - NCT06974851RecruitingPhase 3
Study of HRS9531 for sleep apnea and obesity
This trial tests an injectable medication (HRS9531) to see if it helps people with both obstructive sleep apnea and obesity. It compares the drug to a placebo (no active medicine) to check safety and effectiveness.
Beijing, Beijing MunicipalityAges 18–75 - NCT06982131RecruitingPhase 1
Safety of RO7795081 and its effect on two statins
This study tests a new drug called RO7795081 to see if it changes how your body handles two common statins (pitavastatin and rosuvastatin). It is for adults who are overweight or obese but otherwise healthy, and aims to check the safety of the new drug.
GroningenAges 18–65 - NCT06983431Recruiting
Digital health program for weight management
This study uses a smartphone app and a wearable device to help you manage your weight and health risks. It is for people with a body mass index (BMI) between 27 and 42 who are ready to make healthy changes.
Bratislava, Bratislava RegionAges 25–65 - NCT06987279Recruiting
Probiotics for hormone balance in overweight women
This trial tests whether a specific probiotic, Lactobacillus plantarum, can help regulate hormones in overweight women. It involves taking daily probiotic capsules and providing samples over a period of time.
Zhengzhou, HenanAges 18–40 - NCT06991296Recruiting
Omega-3 supplement study for adults with obesity
This study looks at how omega-3 supplements affect certain fats in the blood of adults with obesity. Researchers want to see if taking these supplements changes these fats in a helpful way.
Kannapolis, North CarolinaAges 45–60 - NCT07012967Recruiting
Taping for breathing and sleep in obesity
This study tests whether kinesio taping improves breathing and sleep quality in people who are overweight or have class 1 or 2 obesity. You will wear a special tape on your body to see if it helps you breathe better and sleep well.
IstanbulAges 18–70 - NCT07027033Recruiting
Oleic acid's effect on cholesterol metabolism in women with obesity
This study tests whether a special type of fatty acid (oleic acid) can change how the body handles cholesterol in women with obesity who are having weight-loss surgery. It will help researchers understand if this nutrient can improve cholesterol metabolism and reduce insulin resistance.
Nantes, FranceAges 18–60 - NCT07032545Recruiting
Broccoli microgreens study for obese breast cancer survivors
This trial tests if eating broccoli microgreens can improve metabolism in obese breast cancer survivors. Participants will avoid other cruciferous vegetables during the study to see how the microgreens affect their health.
Baltimore, MarylandAges Any age
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for obesity?
- Yes. Clin2 currently lists 1,500 recruiting obesity studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obesity trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obesity trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.